VBI Vaccines Inc. (VBIV)
NASDAQ: VBIV · IEX Real-Time Price · USD
0.711
+0.019 (2.75%)
At close: Jul 2, 2024, 4:00 PM
0.770
+0.059 (8.34%)
After-hours: Jul 2, 2024, 6:20 PM EDT
VBI Vaccines Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for VBI Vaccines.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for VBI Vaccines.
Recommendation Trends
| Rating | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains $60 → $6 | Buy | Maintains | $60 → $6 | +743.88% | Apr 13, 2023 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $150 → $60 | Strong Buy → Buy | Downgrades | $150 → $60 | +8,338.82% | Nov 11, 2022 |
| Raymond James | Raymond James | Strong Buy Maintains $180 → $150 | Strong Buy | Maintains | $180 → $150 | +20,997.05% | Aug 9, 2022 |
| Raymond James | Raymond James | Strong Buy Maintains $270 → $180 | Strong Buy | Maintains | $270 → $180 | +25,216.46% | Mar 8, 2022 |
| BMO Capital | BMO Capital | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 27, 2018 |
Financial Forecast
Revenue This Year
13.10M
from 8.68M
Increased by 50.90%
Revenue Next Year
34.81M
from 13.10M
Increased by 165.67%
EPS This Year
-1.25
from -6.03
EPS Next Year
-0.29
from -1.25
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 13.5M | 35.8M | 61.8M |
| Avg | 13.1M | 34.8M | 60.0M |
| Low | 12.6M | 33.4M | 57.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 55.3% | 173.5% | 77.5% |
| Avg | 50.9% | 165.7% | 72.4% |
| Low | 45.0% | 155.3% | 65.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.29 | -0.29 | -0.24 |
| Avg | -1.25 | -0.29 | -0.23 |
| Low | -1.21 | -0.27 | -0.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.